Arrowstreet Capital, Limited Partnership Novartis Ag Transaction History

Arrowstreet Capital, Limited Partnership

$108 Billion
Q1 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Novartis Ag stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 445,201 shares of NVS stock, worth $47.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

445,201

Previous 55,903 696.38%

Holding current value

$47.8 Million

Previous $5.65 Million 662.87%

% of portfolio

0.04%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $37.1 Million - $42.2 Million	389,298 Added 696.38%	445,201 $43.1 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $1.87 Million - $2.06 Million	20,279 Added 56.93%	55,903 $5.65 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $3.37 Million - $3.75 Million	35,624 New	35,624 $3.63 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $316 Million - $367 Million	-3,950,430 Reduced 95.72%	176,652 $16.3 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $189 Million - $231 Million	2,498,355 Added 153.39%	4,127,082 $374 Million

Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $4.44 Million - $5.19 Million	59,534 Added 3.79%	1,628,727 $124 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $34.1 Million - $39.7 Million	-423,365 Reduced 21.25%	1,569,193 $133 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $81 Million - $91.6 Million	1,010,806 Added 102.96%	1,992,558 $175 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $24.3 Million - $26.8 Million	304,383 Added 44.94%	981,752 $85.9 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $27.9 Million - $32.4 Million	340,669 Added 101.18%	677,369 $55.4 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $11.5 Million - $12.7 Million	135,046 Added 66.97%	336,700 $30.7 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $16.4 Million - $19.4 Million	196,839 Added 4088.04%	201,654 $17.2 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $133 Million - $160 Million	-1,699,603 Reduced 99.72%	4,815 $455,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $112 Million - $124 Million	-1,363,892 Reduced 44.45%	1,704,418 $148 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $148 Million - $166 Million	-1,825,719 Reduced 37.31%	3,068,310 $268 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $59.1 Million - $82.7 Million	835,693 Added 20.59%	4,894,029 $404 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $69.6 Million - $78.7 Million	824,906 Added 25.51%	4,058,336 $384 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $18 Million - $19.8 Million	210,489 Added 6.96%	3,233,430 $281 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $125 Million - $154 Million	-1,658,265 Reduced 35.42%	3,022,941 $276 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $107 Million - $122 Million	1,414,976 Added 43.32%	4,681,206 $450 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $11.8 Million - $13.1 Million	160,076 Added 5.15%	3,266,230 $280 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $162 Million - $187 Million	2,416,454 Added 350.36%	3,106,154 $268 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $26.4 Million - $29.9 Million	407,475 Added 144.38%	689,700 $52.1 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $8.65 Million - $10.3 Million	122,825 Added 77.05%	282,225 $22.8 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $9.86 Million - $10.6 Million	136,321 Added 590.67%	159,400 $13.4 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $1.71 Million - $1.78 Million	23,079	23,079 $1.98 Million

Others Institutions Holding NVS

# of Institutions

1,343

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $231B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Novartis Ag Transaction History